So, You’re Now Under A CIA. How can the Medical Information function help?
- Dec 6, 2016
- 2 min read
Updated: Oct 11, 2025
Navigating CIA Oversight: How Medical Information Teams Can Strengthen Compliance and Trust in 2025
Over the past decade, Corporate Integrity Agreements (CIAs) have reshaped how pharmaceutical and biotech companies manage medical information. For organizations operating under or emerging from a CIA, Medical Information (MI) departments play a vital role in re-establishing compliance, credibility, and operational excellence.
At Corelife Group, we’ve observed a consistent truth: when properly structured, Medical Information is not just a compliance function—it’s a credibility engine. Here are three key focus areas to help MI teams excel under today’s intensified scrutiny.
1️⃣ Strengthen CIA Documentation and Governance
Modern CIAs require transparent, auditable documentation of every inquiry and response. MI teams must maintain accurate logs of:
Requestor name and professional credentials
Inquiry nature and topic of interest
Exact language of the question
Identification of any associated sales representative
Evaluation of potential off-label context
Form and content of response, including medical sign-off
Most organizations leverage modern content management systems like IRMS, Veeva MedComms, or Salesforce-integrated MI tools to achieve this. However, compliance isn’t about software—it’s about behavioral consistency and training discipline.
Corelife Group partners with companies to design harmonized training programs, SOPs, and audit-ready documentation frameworks to ensure medical teams meet and exceed CIA standards—without creating administrative burnout.
2️⃣ Drive Insights Through Inquiry Analytics
Quarterly or semiannual inquiry analytics transform compliance data into actionable insights.
By analyzing trends—such as therapy-area inquiry volume, geographic distribution, and frequency of off-label requests—MI leaders can identify risk patterns, inform Medical Affairs strategy, and strengthen Field Medical engagement.
Robust analytics not only enhance compliance; they demonstrate the strategic value of MI to cross-functional partners in Commercial, Regulatory, and Medical Affairs.
3️⃣ Modernize SOPs and Cross-Functional Policies
In 2025, harmonized governance and response procedures are non-negotiable. Areas to reassess include:
What types of medical information can be distributed
Protocols for handling and documenting off-label inquiries
Internal medical review processes
Interactions between sales reps and MI or MSLs
Submission standards for compendia or formulary data
Verification protocols for HCP-authenticated questions
These updates not only protect the organization but also align Medical Affairs functions under a shared, patient-first compliance culture.
Your Compliance. Our Core Expertise.
If your company is preparing for an audit, revising SOPs, or building Medical Affairs infrastructure under new compliance demands, Corelife Group can help.
Our team of former Global Medical Affairs executives, compliance strategists, and organizational design experts can assess, redesign, and train your MI and Medical Affairs teams to ensure full regulatory alignment—while maintaining the agility your science demands.
📞 Book a consultation with Dr. Anne Arvizu to strengthen your Medical Affairs operations and CIA compliance with confidence.
References:
U.S. Department of Health and Human Services, OIG Corporate Integrity Agreements, 2024
McKinsey & Company, Strengthening Compliance in Biopharma through Data Transparency, 2023
DIA Medical Communications Annual Report, 2023
Comments